Medical Grade Tri isopropanolamine Sales

Medical Grade Tri Isopropanolamine Sales Market Outlook

The global medical grade tri isopropanolamine market is poised for significant growth, expected to reach approximately USD 250 million by 2035, with a compound annual growth rate (CAGR) of about 7.5% during the forecast period from 2025 to 2035. The increasing demand for versatile chemical compounds in pharmaceuticals, personal care products, and industrial applications is driving this growth. As more industries recognize the multifunctional benefits of tri isopropanolamine, including its emulsifying, stabilizing, and surfactant properties, its incorporation into various products is on the rise. This trend is further supported by advancements in formulation technologies and a growing focus on developing high-purity ingredients for sensitive applications, including medical and cosmetic uses. Additionally, the rise in healthcare expenditure and the expanding pharmaceutical landscape in emerging economies are expected to significantly contribute to market dynamics.

Growth Factor of the Market

The growth factors for the medical grade tri isopropanolamine market are multifaceted, stemming from several industry trends and consumer preferences. Firstly, the pharmaceutical industry's accelerated growth, particularly post-pandemic, has increased the demand for high-quality excipients and ingredients, driving the utilization of tri isopropanolamine in various formulations. Furthermore, the expanding personal care sector, particularly in skincare and cosmetic products, showcases a rising trend towards using safe, effective ingredients, further pushing the demand for medical-grade compounds. The industrial applications of tri isopropanolamine in sectors such as coatings, textiles, and automotive also stimulate market growth, as industries continuously seek to enhance product performance and sustainability. Additionally, regulatory advancements and stringent quality standards in many regions promote the adoption of medical-grade ingredients, ensuring safety and efficacy for end-users. The growing awareness of product sustainability and consumer safety has also led to an increased focus on sourcing high-purity chemicals, which is a significant factor in the overall market's expansion.

Key Highlights of the Market

• The medical grade tri isopropanolamine market is projected to reach USD 250 million by 2035.
• Significant applications in pharmaceuticals and personal care products fuel market demand.
• Liquid form of tri isopropanolamine is the most widely used type.
• North America is expected to dominate the market, followed closely by Europe and Asia Pacific.
• The CAGR for the market is estimated at 7.5% from 2025 to 2035.

By Product Type

Liquid Form:

Liquid form of tri isopropanolamine is the predominant segment within the medical grade market due to its versatility and ease of integration into various formulations. It is widely utilized in pharmaceutical applications, where it serves as an important emulsifying agent and stabilizer, enhancing the efficacy and uniformity of drug formulations. The liquid form is highly preferred for its ability to be precisely dosed and mixed, which is crucial for developing high-quality products. Additionally, this form is favored in personal care products, where it can enhance the texture and overall performance of creams and lotions. The increasing trend toward liquid formulations in various industries is anticipated to sustain this segment's growth, as manufacturers prioritize efficiency in production processes.

Powder Form:

The powder form of tri isopropanolamine occupies a significant niche within the market, especially in industrial applications where solid-state ingredients are essential. This form is often utilized in formulations requiring stable, long-lasting properties, such as in coatings and adhesives. The powder is easier to handle and store, making it an attractive option for manufacturers who need to maintain product integrity over time. Furthermore, in the pharmaceutical industry, powder forms are essential for creating solid dosage forms like tablets and capsules, where precise measurement and formulation are critical. The demand for powder ingredients is expected to grow as industries increasingly focus on the shelf-life stability and efficacy of their products.

Gel Form:

Gel form of tri isopropanolamine is increasingly popular, particularly in the cosmetic and pharmaceutical sectors, where texture and feel are vital to consumer acceptance. Gels offer unique properties such as ease of application and a pleasant sensory experience, making them ideal for skincare products and topical medications. As the demand for products that provide immediate and noticeable effects rises, manufacturers are looking toward gel formulations to meet consumer expectations. The gel form is also advantageous in controlled delivery systems, where the release of active ingredients must be regulated over time. The growth of the personal care industry, along with trends favoring multifunctional and innovative formulations, is expected to bolster the demand for this segment significantly.

Capsule Form:

Capsule form of tri isopropanolamine is essential for pharmaceuticals, particularly in drug delivery systems. Capsules offer a convenient and efficient way to administer medication, ensuring accurate dosing and improved patient compliance. The use of tri isopropanolamine in capsule formulations can enhance the stability of active ingredients while also allowing for controlled release properties. This form is particularly beneficial for sensitive compounds that may degrade in other forms. As the healthcare sector continues to explore innovative delivery mechanisms to improve therapeutic outcomes, the capsule segment is forecasted to experience robust growth in the coming years, driven by ongoing research and development in pharmaceutical formulations.

Tablet Form:

The tablet form of tri isopropanolamine is crucial in the pharmaceutical industry, known for its ease of administration and precise dosage capabilities. Tablets provide a stable delivery method for various active ingredients, enhancing their efficacy and shelf life. Tri isopropanolamine's role in tablet formulations often revolves around its ability to act as a binder and stabilizer, crucial for maintaining tablet integrity during storage and transport. As the demand for over-the-counter medications increases, the tablet segment is expected to witness substantial growth, particularly as manufacturers focus on developing innovative formulations that cater to a diverse consumer base. The rise in self-medication trends globally further supports the growth of the tablet form in the medical grade market.

By Application

Pharmaceuticals:

The pharmaceuticals segment is the largest consumer of medical grade tri isopropanolamine, driven by the increasing need for high-quality excipients and additives in drug formulations. Its role as an emulsifier and stabilizing agent is pivotal for ensuring the uniformity and efficacy of various medications, including oral and topical therapies. The ongoing innovations in pharmaceuticals, such as the development of novel drug delivery systems and bioavailability enhancement techniques, further amplify the demand for tri isopropanolamine. The expansion of the global pharmaceuticals industry, particularly in emerging markets, is set to fuel the growth of this segment, as companies prioritize the development of safe and effective formulations for patients.

Personal Care Products:

In the personal care products segment, tri isopropanolamine is increasingly utilized for its emulsifying and stabilizing properties, which are essential for formulating creams, lotions, and other topical applications. With a growing consumer focus on high-quality, effective personal care products, manufacturers are turning to medical-grade ingredients to ensure safety and performance. This segment is particularly driven by trends favoring natural and organic formulations, as consumers demand products that are both effective and safe for use. The expanding global personal care market, bolstered by rising disposable incomes and changing lifestyles, is expected to significantly propel the demand for tri isopropanolamine in this sector.

Industrial Applications:

The industrial applications of tri isopropanolamine are diverse, encompassing areas such as coatings, textiles, and adhesives. Its versatility as a surfactant allows it to be utilized in various formulations that require enhanced performance characteristics, such as improved adhesion and stability. As industries increasingly focus on optimizing product performance while adhering to stringent safety regulations, the demand for medical-grade ingredients like tri isopropanolamine is rising. Moreover, the trend toward sustainability in manufacturing processes encourages the use of eco-friendly and high-purity chemicals, further driving the adoption of tri isopropanolamine in industrial applications.

Others:

The 'Others' category captures additional applications of tri isopropanolamine that do not fall under the primary categories of pharmaceuticals, personal care, or industrial applications. This segment may include niche markets such as agricultural products, food processing, and specialty chemicals. As the awareness of the multifunctional properties of tri isopropanolamine grows, its application scope is likely to expand, leading to increased adoption in various sectors. The ongoing research into innovative applications and formulations will likely support the growth of this segment, catering to specialized needs across different industries.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel for medical grade tri isopropanolamine, primarily because manufacturers often prefer to maintain closer relationships with their clients and ensure product quality. This channel allows for personalized service, tailored solutions, and direct feedback, which can facilitate better product development and customer satisfaction. The pharmaceutical and personal care sectors particularly benefit from direct sales strategies, where companies aim to supply high-grade ingredients tailored to specific formulations. As the demand for specialty chemicals grows, the direct sales channel is expected to expand, providing manufacturers with strategic advantages in terms of market penetration and customer loyalty.

Distributors:

Distributors play a crucial role in making medical grade tri isopropanolamine available to a wider range of customers across various industries. They provide essential logistics support, ensuring that the product is available in the right quantities and at the right time for manufacturers and formulators. The use of distributors is especially prevalent in regional markets where manufacturers may not have established direct sales capabilities. This channel helps bridge the gap between production and consumption, allowing for more efficient supply chains. As industries expand and the demand for tri isopropanolamine grows, the distributor network is expected to strengthen, contributing significantly to market dynamics.

Online Retail:

Online retail has emerged as a vital distribution channel for medical grade tri isopropanolamine, driven by the increasing reliance on e-commerce platforms for purchasing chemicals and ingredients. The convenience of online ordering, with the ability to compare products and prices, appeals to many manufacturers and formulators. Additionally, the COVID-19 pandemic accelerated the shift toward online procurement, with many businesses recognizing the efficiency and safety of digital transactions. As e-commerce continues to evolve, offering enhanced user experiences and streamlined logistics, the online retail channel is anticipated to grow substantially, providing new opportunities for companies in the medical grade chemical market.

By Ingredient Type

Tri Isopropanolamine 99%:

Tri isopropanolamine 99% is recognized for its high purity, making it a preferred choice for applications that require stringent quality standards, such as in the pharmaceutical industry. This ingredient type ensures the safety and efficacy of formulations, particularly in sensitive applications like drug delivery systems and topical products. The increasing regulatory requirements for pharmaceutical ingredients are driving the demand for high-purity chemicals, propelling the market for tri isopropanolamine 99%. As manufacturers focus on developing more effective and safe products, the use of high-grade ingredients is expected to rise, further supporting the growth of this segment.

Tri Isopropanolamine 95%:

Tri isopropanolamine 95% serves as a versatile ingredient across various applications, offering a balance between cost and performance. While slightly lower in purity than the 99% variant, it still meets the requirements for many personal care and industrial applications. This ingredient type is particularly popular in formulations where high purity is advantageous but not strictly necessary. The demand for tri isopropanolamine 95% is fueled by the rising need for cost-effective solutions in industries that prioritize high performance while keeping production costs manageable. As the market grows, this ingredient is expected to maintain a strong presence due to its adaptability across various sectors.

Tri Isopropanolamine 90%:

Tri isopropanolamine 90% is often used in applications where the balance of performance and cost is critical. This ingredient type finds use in formulations where the precise purity level is less crucial, such as in some industrial applications and lower-end personal care products. Its affordability and functional properties make it an attractive option for manufacturers looking to optimize their formulations without compromising too much on quality. The growth of this segment will likely continue as industries look to streamline their production processes while still utilizing effective chemical compounds.

Tri Isopropanolamine 85%:

Tri isopropanolamine 85% serves specific niche applications where cost is a significant concern, and the purity level is secondary to performance. This ingredient type is utilized in various industrial formulations, such as coatings and adhesives, where high purity is not always a priority. Its use in lower-cost formulations allows manufacturers to maintain competitiveness in pricing while still delivering functional products to consumers. The growth in industrial applications particularly supports the demand for this ingredient type, as companies seek effective yet affordable solutions for their production needs.

Tri Isopropanolamine 80%:

Tri isopropanolamine 80% is primarily used in less stringent applications where performance is required but high purity is not essential. Its affordability makes it a viable option for bulk manufacturing in various industries, including textile and automotive, where cost efficiencies are crucial. Manufacturers often select this ingredient type for formulations that do not necessitate high-purity chemicals, helping maintain competitive pricing in the market. As demands for lower-cost formulations increase, this segment is expected to experience steady growth, catering to manufacturers who prioritize cost-efficiency without sacrificing essential performance attributes.

By Region

North America leads the medical grade tri isopropanolamine market, driven by the well-established pharmaceutical and personal care industries. The region accounts for approximately 40% of the global market share, with robust growth expected at a CAGR of around 6.5% through 2035. The increasing focus on high-purity ingredients, coupled with stringent regulatory frameworks, has encouraged manufacturers to adopt medical-grade tri isopropanolamine in their formulations. The pharmaceutical sector's continuous innovation and the growing demand for safety and efficacy in personal care products are key factors propelling growth in this region.

Europe follows closely, representing about 30% of the global market share, with growth projected at a CAGR of around 7% during the forecast period. The strong regulatory environment within the European Union mandates the use of high-quality ingredients, boosting the demand for medical-grade tri isopropanolamine. Additionally, the rising consumer awareness regarding safety and efficacy in personal care products drives manufacturers to prioritize high-purity chemicals in their formulations. As manufacturers in Europe continue to focus on sustainability and performance, the demand for tri isopropanolamine is expected to grow significantly, supporting various applications across the region.

Opportunities

The opportunities in the medical grade tri isopropanolamine market are vast, particularly as industries continue to innovate and expand. One major opportunity lies in the growing demand for high-purity chemicals, driven by an increase in regulatory standards and consumer expectations. As the pharmaceutical and personal care industries seek to improve product quality and efficacy, manufacturers are motivated to invest in high-grade ingredients like tri isopropanolamine. This focus on quality may open new avenues for research and product development, allowing companies to create innovative formulations that cater to evolving market needs. Moreover, emerging markets in Asia Pacific and Latin America present lucrative opportunities for manufacturers, as rising disposable incomes and urbanization drive demand for pharmaceuticals and personal care products.

In addition to emerging markets, the increasing trend toward sustainability and eco-friendly formulations offers further opportunities for the tri isopropanolamine market. As consumers become more conscious of the environmental impact of their purchases, manufacturers are searching for sustainable chemical alternatives that meet both performance and environmental standards. This shift in consumer behavior encourages companies to reformulate their products using high-quality, sustainable ingredients, which could significantly enhance the adoption of medical-grade tri isopropanolamine across various applications. The growing collaboration between manufacturers, research institutions, and regulatory bodies may also yield innovative solutions that enhance product performance and compliance, propelling market growth in the coming years.

Threats

Despite the positive outlook for the medical grade tri isopropanolamine market, several threats could hinder its growth. One significant challenge is the increasing competition from alternative ingredients that can provide similar functionalities at a lower price point. As manufacturers explore cost-effective solutions, the market for tri isopropanolamine may face pressure from substitutes that can offer comparable performance without the same purity requirements. This shift could lead to a decline in market share for tri isopropanolamine in certain applications, particularly in industries sensitive to cost fluctuations. Furthermore, fluctuations in raw material prices can also impact the overall market dynamics, affecting manufacturers' profit margins and pricing strategies.

Another significant threat comes from stringent regulatory frameworks that govern the use of chemicals in various industries. The evolving landscape of regulations can create challenges for manufacturers, requiring ongoing investment in compliance and quality assurance. Non-compliance with these regulations can result in hefty fines and damage to brand reputation, thus deterring potential market entrants and curtailing growth opportunities for established players. Additionally, the market's reliance on specific applications, such as pharmaceuticals and personal care products, may render it vulnerable to economic downturns or shifts in consumer preferences. Manufacturers must continuously adapt to changing market conditions to mitigate these threats and sustain growth in the medical grade tri isopropanolamine market.

Competitor Outlook

• Huntsman Corporation
• BASF SE
• Eastman Chemical Company
• Evonik Industries AG
• Solvay SA
• Kraton Corporation
• Alkyl Amines Chemicals Ltd.
• Lonza Group AG
• Croda International Plc
• Oxiteno S.A.
• INDSPEC Chemical Corporation
• Emery Oleochemicals
• Gujarat Alkalies and Chemicals Limited
• Kao Corporation
• Hindustan Organic Chemicals Limited

The competitive landscape of the medical grade tri isopropanolamine market is characterized by a mix of established players and emerging companies striving to capture market share. Major companies like Huntsman Corporation and BASF SE lead the market owing to their extensive product portfolios and strong R&D capabilities. These corporations continually innovate to develop high-quality, efficient formulations that meet the rigorous standards of the pharmaceutical and personal care sectors. Their global presence and established distribution networks give them a competitive advantage, allowing them to cater to diverse customer needs effectively.

Eastman Chemical Company and Evonik Industries AG are also significant players, focusing on sustainability and eco-friendly product development. Their commitment to environmental responsibility resonates with the growing consumer demand for sustainable choices, further enhancing their market positioning. By investing in research and development, these companies aim to stay ahead in innovation and address the evolving industry demands. Moreover, their strategic partnerships and collaborations with other industry leaders and research institutions strengthen their ability to deliver innovative solutions that align with market trends.

As the market continues to evolve, middle-market players like Alkyl Amines Chemicals Ltd. and Gujarat Alkalies and Chemicals Limited are also gaining traction. These companies leverage their agility and niche market focus to capture opportunities, particularly in emerging markets. Their competitive pricing strategies and specialized product offerings allow them to cater to specific applications effectively. The combination of established giants and emerging players creates a dynamic and competitive environment in the medical grade tri isopropanolamine market, fostering innovation and ensuring diverse options for end-users.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Solvay SA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Oxiteno S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Lonza Group AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Kao Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Kraton Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Emery Oleochemicals
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Evonik Industries AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Huntsman Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Croda International Plc
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Eastman Chemical Company
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Alkyl Amines Chemicals Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 INDSPEC Chemical Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hindustan Organic Chemicals Limited
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Gujarat Alkalies and Chemicals Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Medical Grade Tri isopropanolamine Sales Market, By Application
    • 6.1.1 Pharmaceuticals
    • 6.1.2 Personal Care Products
    • 6.1.3 Industrial Applications
    • 6.1.4 Others
  • 6.2 Medical Grade Tri isopropanolamine Sales Market, By Product Type
    • 6.2.1 Liquid Form
    • 6.2.2 Powder Form
    • 6.2.3 Gel Form
    • 6.2.4 Capsule Form
    • 6.2.5 Tablet Form
  • 6.3 Medical Grade Tri isopropanolamine Sales Market, By Ingredient Type
    • 6.3.1 Tri isopropanolamine 99%
    • 6.3.2 Tri isopropanolamine 95%
    • 6.3.3 Tri isopropanolamine 90%
    • 6.3.4 Tri isopropanolamine 85%
    • 6.3.5 Tri isopropanolamine 80%
  • 6.4 Medical Grade Tri isopropanolamine Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributors
    • 6.4.3 Online Retail

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Medical Grade Tri isopropanolamine Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Medical Grade Tri isopropanolamine Sales market is categorized based on

By Product Type

• Liquid Form
• Powder Form
• Gel Form
• Capsule Form
• Tablet Form

By Application

• Pharmaceuticals
• Personal Care Products
• Industrial Applications
• Others

By Distribution Channel

• Direct Sales
• Distributors
• Online Retail

By Ingredient Type

• Tri isopropanolamine 99%
• Tri isopropanolamine 95%
• Tri isopropanolamine 90%
• Tri isopropanolamine 85%
• Tri isopropanolamine 80%

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Huntsman Corporation
• BASF SE
• Eastman Chemical Company
• Evonik Industries AG
• Solvay SA
• Kraton Corporation
• Alkyl Amines Chemicals Ltd.
• Lonza Group AG
• Croda International Plc
• Oxiteno S.A.
• INDSPEC Chemical Corporation
• Emery Oleochemicals
• Gujarat Alkalies and Chemicals Limited
• Kao Corporation
• Hindustan Organic Chemicals Limited